Protagonist Therapeutics
PTGX
PTGX
132 hedge funds and large institutions have $817M invested in Protagonist Therapeutics in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 31
62% less capital invested
Capital invested by funds: $2.15B → $817M (-$1.33B)
80% less funds holding in top 10
Funds holding in top 10: 10 → 2 (-8)
Holders
132
Holding in Top 10
2
Calls
$25.9M
Puts
$15.1M
Top Buyers
| 1 | +$57.3M | |
| 2 | +$26.6M | |
| 3 | +$25.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.91M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.63M |
Top Sellers
| 1 | -$155M | |
| 2 | -$37.9M | |
| 3 | -$31.1M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$26.9M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$24.1M |